Therefore, on the basis of the integration of our current findings with previous research evidence, we hypothesize that the upregulated expression of CPT1A in drug-resistant colorectal cancer cells may serve as a potential biomarker for chemotherapy resistance in this disease. Here, CPT1A is linked to colorectal cancer.